• Urologic oncology · Jul 2004

    Randomized Controlled Trial Multicenter Study Clinical Trial

    The prostate, lung, colon, and ovarian (PLCO) cancer screening trial: Status and promise.

    • Gerald L Andriole, Douglas Reding, Richard B Hayes, Philip C Prorok, John K Gohagan, and PLCO Steering Committee.
    • Division of Urologic Surgery, Washington University School of Medicine, Washington University in St. Louis, 4960 Children's Place, Campus Box 8242, St. Louis, MO 63110, USA. andrioleg@wustl.edu
    • Urol. Oncol. 2004 Jul 1;22(4):358-61.

    AbstractThe Prostate, Lung, Cancer, and Ovarian Cancer Screening Trial is a randomized, multicenter, study evaluating whether screening for prostate, lung, colon, and ovarian cancer will reduce cancer-specific mortality. More than 155,000 participants have been identified and will be monitored through 2015. A biorepository of screened individuals and control participants has been created. Together, the data derived from the intervention and control arms and material in the biorepository provide a valuable resource to allow identification and testing of novel biomarkers for human disease.Copyright 2004 Elsevier Inc.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.